首页> 美国卫生研究院文献>Oncotarget >Haploinsufficiency of the c-myc transcriptional repressor FIR as a dominant negative-alternative splicing model promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1
【2h】

Haploinsufficiency of the c-myc transcriptional repressor FIR as a dominant negative-alternative splicing model promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1

机译:单体型不足的c-myc转录阻遏物FIR作为主要的负-替代剪接模型通过激活Notch1促进了p53依赖性T细胞急性淋巴细胞白血病的进展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

FUSE-binding protein (FBP)-interacting repressor (FIR) is a c-myc transcriptional suppressor. A splice variant of FIR that lacks exon 2 in the transcriptional repressor domain (FIRΔexon2) upregulates c-myc transcription by inactivating wild-type FIR. The ratio of FIRΔexon2/FIR mRNA was increased in human colorectal cancer and hepatocellular carcinoma tissues. Because FIRΔexon2 is considered to be a dominant negative regulator of FIR, FIR heterozygous knockout (FIR+/−) C57BL6 mice were generated. FIR complete knockout (FIR−/−) was embryonic lethal before E9.5; therefore, it is essential for embryogenesis. This strongly suggests that insufficiency of FIR is crucial for carcinogenesis. FIR+/− mice exhibited prominent c-myc mRNA upregulation, particularly in the peripheral blood (PB), without any significant pathogenic phenotype. Furthermore, elevated FIRΔexon2/FIR mRNA expression was detected in human leukemia samples and cell lines. Because the single knockout of TP53 generates thymic lymphoma, FIR+/−TP53−/− generated T-cell type acute lymphocytic/lymphoblastic leukemia (T-ALL) with increased organ or bone marrow invasion with poor prognosis. RNA-sequencing analysis of sorted thymic lymphoma cells revealed that the Notch signaling pathway was activated significantly in FIR+/−TP53−/− compared with that in FIR+/+TP53−/− mice. Notch1 mRNA expression in sorted thymic lymphoma cells was confirmed using qRT-PCR. In addition, flow cytometry revealed that c-myc mRNA was negatively correlated with FIR but positively correlated with Notch1 in sorted T-ALL/thymic lymphoma cells. Moreover, the knockdown of TP53 or c-myc using siRNA decreased Notch1 expression in cancer cells. In addition, an adenovirus vector encoding FIRΔexon2 cDNA increased bleomycin-induced DNA damage. Taken together, these data suggest that the altered expression of FIRΔexon2 increased Notch1 at least partially by activating c-Myc via a TP53-independent pathway. In conclusion, the alternative splicing of FIR, which generates FIRΔexon2, may contribute to both colorectal carcinogenesis and leukemogenesis.
机译:FUSE结合蛋白(FBP)相互作用阻遏物(FIR)是c-myc转录抑制剂。 FIR的剪接变体在转录阻遏域(FIRΔexon2)中缺少外显子2,可通过灭活野生型FIR来上调c-myc转录。在人类大肠癌和肝细胞癌组织中,FIRΔexon2/ FIR mRNA的比例增加。因为FIRΔexon2被认为是FIR的主要负调节剂,所以产生了FIR杂合敲除(FIR + /-/-)C57BL6小鼠。 FIR完全敲除(FIR -/-)在E9.5之前是致死性的;因此,对于胚胎发生至关重要。这强烈表明,FIR不足对于致癌至关重要。 FIR +/- 小鼠表现出明显的c-myc mRNA上调,特别是在外周血(PB)中,没有任何明显的致病表型。此外,在人白血病样品和细胞系中检测到FIRΔexon2/ FIR mRNA表达升高。由于单敲除TP53会产生胸腺淋巴瘤,因此FIR +/- TP53 -/-会产生器官增加的T细胞型急性淋巴细胞/淋巴细胞白血病(T-ALL)或骨髓浸润预后差。胸腺淋巴瘤细胞的RNA测序分析表明,与FIR +相比,FIR +/- TP53 -/-中Notch信号通路被显着激活/ + TP53 -/-小鼠。用qRT-PCR证实了 Notch1 mRNA在分选的胸腺淋巴瘤细胞中的表达。此外,流式细胞仪显示,在分选的T-ALL /胸腺淋巴瘤中, c-myc mRNA与 FIR 呈负相关,而与 Notch1 正相关。细胞。此外,使用siRNA敲除 TP53 c-myc 会降低癌细胞中Notch1的表达。此外,编码FIRΔexon2cDNA的腺病毒载体增加了博来霉素诱导的DNA损伤。综上所述,这些数据表明FIRΔexon2的表达改变至少部分地通过经由不依赖TP53的途径激活c-Myc来增加Notch1。总之,生成FIRΔexon2的FIR的可变剪接可能有助于结直肠癌的发生和白血病的发生。

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号